|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019704,
umls-concept:C0031437,
umls-concept:C0043474,
umls-concept:C0080103,
umls-concept:C0205460,
umls-concept:C0231221,
umls-concept:C0237401,
umls-concept:C0242656,
umls-concept:C0683598,
umls-concept:C1527148,
umls-concept:C2709058
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1993-2-2
|
|
pubmed:abstractText |
To determine which parameters are associated with clinical progression during zidovudine treatment of asymptomatic HIV-1-infected individuals.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1259-64
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:1282015-Cytopathogenic Effect, Viral,
pubmed-meshheading:1282015-Drug Resistance, Microbial,
pubmed-meshheading:1282015-HIV Infections,
pubmed-meshheading:1282015-HIV-1,
pubmed-meshheading:1282015-Humans,
pubmed-meshheading:1282015-Male,
pubmed-meshheading:1282015-Mutation,
pubmed-meshheading:1282015-Phenotype,
pubmed-meshheading:1282015-RNA-Directed DNA Polymerase,
pubmed-meshheading:1282015-Time Factors,
pubmed-meshheading:1282015-Zidovudine
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment.
|
|
pubmed:affiliation |
Department of Virology, University of Amsterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article
|
